Tick-borne disease

An expanding geographic threat

Tick-borne diseases (TBDs) occur worldwide, but historically, only certain pockets of the United States posed a risk for infection. However, the geographic range of ticks continues to expand in North America, leading to higher risks of TBD exposure for the public. As a result of increasing exposure and the rising number of potential tick-borne pathogens, it is increasingly important to recognize who to test, when to test, and what test to use for patients who present with TBD symptoms.

We offer a full menu of individual tests and panels that aid in the diagnosis of TBDs. In addition to our comprehensive testing menu, we have developed multiple TBD testing algorithms, including modified two-tiered assays, to help guide and optimize diagnostic testing.

Tick-borne disease Test menu

Panels

Serology panels

Molecular panel


Alpha-gal Syndrome

Key testing

Highlights


Anaplasmosis

Key testing


Babesiosis

Key testing


Borrelia miyamotoi disease

Key testing


Ehrlichiosis

Key testing


Heartland virus

Key testing


Lyme disease

Key testing


Powassan virus

Key testing


Rocky Mountain spotted fever

Initial symptoms of Rocky Mountain spotted fever, which is caused by the Rickettsia rickettsii bacterium and transferred to humans through the bites of hard-bodied ticks, can be mild and non-specific. Lacking prompt and proper treatment, however, the infection can quickly progress to more severe symptoms. Including altered mental status, cerebral swelling, respiratory distress, and multi-organ damage, symptoms can lead to death if left untreated. Accurate, timely diagnosis is vital to prevent against serious harm.

Key testing


Resources
INTERESTED IN LEARNING MORE?

Fill out the form below and one of our specialists will be in touch.